Intensity Therapeutics In... (INTS)

NASDAQ: INTS · Real-Time Price · USD

0.60

-0.04 (-5.79%)

At close: Apr 29, 2025, 3:59 PM

0.60

-0.05%

After-hours: Apr 29, 2025, 07:50 PM EDT

Intensity Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-16.27M	-10.54M	-7.58M	-7.9M	-6.03M	-5.38M
Depreciation & Amortization	n/a	n/a	179.04K	n/a	n/a	n/a
Stock-Based Compensation	3.07M	1.4M	1.17M	719.82K	555.49K	561.38K
Other Working Capital	301K	-2.26M	326.02K	227K	159.22K	104.36K
Other Non-Cash Items	-58K	2.57M	179.04K	172.11K	116.83K	95.21K
Deferred Income Tax	n/a	n/a	-179.04K	n/a	n/a	n/a
Change in Working Capital	-1.97M	-633K	756.69K	176.8K	-12.03K	306.91K
Operating Cash Flow	-15.22M	-7.21M	-5.48M	-6.83M	-5.37M	-4.42M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-3.06M	-15.05M	n/a	n/a	-10.9M	-7.07M
Sales Maturities Of Investments	n/a	9.03M	n/a	n/a	15.46M	8.77M
Other Investing Acitivies	9.41M	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	6.35M	-6.02M	n/a	n/a	4.56M	1.7M
Debt Repayment	n/a	230K	2.25M	2M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-332K	-2.18M	n/a	50K	25K	n/a
Financial Cash Flow	2.9M	20.47M	2.25M	2.05M	6.29M	3.86M
Net Cash Flow	-5.97M	7.24M	-3.23M	-4.78M	5.49M	1.14M
Free Cash Flow	-15.22M	-7.21M	-5.48M	-6.83M	-5.37M	-4.42M